Table 1.
Type of tumor |
Size of primary tumor |
P-value | ||||
---|---|---|---|---|---|---|
<= 4 cm | 4 - 6 cm | 6 - 9 cm | > 9 cm | |||
No. of patients by tumor size group [%] |
ALL |
32 [30] |
24 [23] |
25 [24] |
25 [24] |
0.034 (PGL vs. PHEO) |
PGL |
31 [35] |
19 [21] |
20 [22] |
19 [21] |
||
PHEO |
1 [6] |
5 [29] |
5 [29] |
6 [35] |
||
Probability of 5-year survival [%] |
ALL |
94.1 |
95 |
83.4 |
88 |
0.16 |
PGL |
93.8 |
93.8 |
85.0 |
89.5 |
0.26 |
|
PHEO |
100 |
100 |
75.0 |
83.3 |
0.39 |
|
Years to death
(median)
|
ALL |
>55 |
>25 |
12 |
20 |
0.035 |
PGL |
>55 |
>25 |
12 |
20 |
0.030 |
|
PHEO |
>5 |
9 |
8 |
17 |
0.58 |
|
Survival Hazard Ratio |
ALL |
1 |
4.6 |
12.21 |
5.82 |
|
No. of deceased patients [%] |
ALL |
1 [3.13] |
6 [25] |
10 [40] |
6 [24] |
|
Median age at diagnosis |
ALL |
32 |
25 |
30 |
31 |
0.44 |
Median year of diagnosis |
ALL |
2007 |
2003 |
2004 |
2003 |
0.043 |
Years to metastases (median) |
ALL |
8 |
4 |
3 |
1 |
0.0008 |
Probability of 5-year “metastases-free interval” [%] |
ALL |
66.2 |
34.6 |
25.1 |
19.2 |
0.0002 |
Probability of 10-year “metastases-free interval” [%] | ALL | 34.0 | 12.4 | 16.8 | 19.2 | 0.004 |